Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of diabetes on mild cognitive impairment (MCI) and its conversion to dementia remains controversial. We sought to examine whether diabetes and pre-diabetes are associated with MCI and accelerate the progression from MCI to dementia. RESEARCH DESIGN AND METHODS: In the Kungsholmen Project, 963 cognitively intact participants and 302 subjects with MCI (120 with amnestic MCI [aMCI ] and 182 with other cognitive impairment no dementia [oCIND]) age ≥75 years were identified at baseline. The two cohorts were followed for 9 years to detect the incident MCI and dementia following international criteria. Diabetes was ascertained based on a medical examination, hypoglycemic medication use, and random blood glucose level ≥11.0 mmol/l. Pre-diabetes was defined as random blood glucose level of 7.8–11.0 mmol/l in diabetes-free participants. Data were analyzed using standard and time-dependent Cox proportional-hazards models. RESULTS: During the follow-up period, in the cognitively intact cohort, 182 people developed MCI (42 aMCI and 140 oCIND), and 212 developed dementia. In the MCI cohort, 155 subjects progressed to dementia, the multi-adjusted hazard ratio (95% CI) of dementia was 2.87 (1.30–6.34) for diabetes, and 4.96 (2.27–10.84) for pre-diabetes. In a Kaplan-Meier survival analysis, diabetes and pre-diabetes accelerated the progression from MCI to dementia by 3.18 years. Diabetes and pre-diabetes were neither cross-sectionally nor longitudinally associated with MCI. CONCLUSIONS: Diabetes and pre-diabetes substantially accelerate the progression from MCI to dementia, and anticipate dementia occurrence by more than 3 years in people with MCI. The association of diabetes with the development of MCI is less evident in old people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysfunction of multiple organ systems manifests similarly in diabetes as it does during normal chronological ageing, but in diabetes this frequently occurs at a younger age [2–4].”
From Cellular senescence: at the nexus between ageing and diabetes (2019) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“ADRDA) criteria (34), and to the National Institute of Neurological Disorders”
BackgroundDiagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.)
Drake, M. (1988) · The American Journal of Occupational Therapy · doi:10.5014/ajot.42.10.683b · Cited by 5,240
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“Different criteria and subdivisions of MCI have been proposed and modified over time (12).”
BackgroundSelf-citationRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 3×
“This cohort included 120 aMCI subjects who had memory complaints and objective episodic memory impairment (14,24) and 182 oCIND subjects who had significant impairment in global cognitive performance, as defined in a previous report (15).”
BackgroundMethodSelf-citationGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citation. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 2×
“Furthermore, many large population-based longitudinal studies have demonstrated an increased risk of dementia in people with diabetes (2), but the association of diabetes with Alzheimer’s disease is less evident in some studies (2,3).”
BackgroundMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · cited 1×
“Interestingly, a clinicopathologic study suggested that there may be a shared predisposition for developing amyloid in both the pancreas and the brain (40).”
Background
Research works printed but not linked: 3
- Nordic Council on Medicines, 1985, Guidelines for ATC Classification
- World Health Organization, 1999, Definition, Diabetes and Classification of Diabetes Mellitus and Its Complications
- Xu W . Diabetes mellitus and the risk of dementia: a population-based study. Karolinska Institutet. The frame of the thesis available at http://diss.kib.ki.se/2008/978–91-7357–516-4. Accessed 16 May 2008
Cited by
Items 101–200 of 264
Dong, W., Li, P., Zhou, Y., Sun, Y., Xu, J. B., Liu, Y., Li, X., Li, J., Bian, Z., & Wang, L. (2020) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2020.3004462 · Cited by 29
HIF-1α serves as a co-linker between AD and T2DM
Yang, H. T., Ren, K., Zhang, Y., Yang, L., Cao, H., Yuan, X., Su, L., Li, H., Feng, X., & Liu, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116158 · Cited by 29
Cheng, P., Sy, H., Wu, S., Wang, W., & Chen, Y. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.003 · Cited by 28
“, 2004) or early stage (Ruis et al., 2009; Xu et al., 2010) of diabetes have a higher risk of cognitive impairment, our study showed that women and men had an increased risk of approximately 46% and 76%, respectively, for developing dementia after type 2 diabetes was first diagnosed.”
BackgroundAlosco, M. L., Spitznagel, M. B., Cohen, R. A., Sweet, L. H., Josephson, R., Hughes, J. W., Rosneck, J., & Gunstad, J. (2014) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515114535331 · Cited by 30
GLP‐1 improves neuropathology after murine cold lesion brain trauma
DellaValle, B., Hempel, C., Johansen, F. F., & Kurtzhals, J. A. L. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.99 · Cited by 27
Verny, C., Doucet, J., Bauduceau, B., Constans, T., Mondon, K., & Floch, J. P. L. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.10.006 · Cited by 30
“1878-7649/ 2014 Elsevier Masson SAS and European Union Geriatric Medicine Socie well as Alzheimer’s disease [6–13].”
BackgroundAtif, M., Saleem, Q., & Scahill, S. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0600-3 · Cited by 30
Arya, S., Claud, S. L., Cantrell, K. L., & Bowers, M. T. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00516 · Cited by 28
Apathy in Older Patients with Type 2 Diabetes
Bruce, D. G., Nelson, M. E., Mace, J. L., Davis, W. A., Davis, T. M. E., & Starkstein, S. E. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.09.010 · Cited by 26
Xu, W., Hu, X., Zhang, X., Ling, C., Wang, C., & Gao, L. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s333373 · Cited by 26
Self-citationSkapare, E., Konrāde, I., Liepinsh, E., Makrecka‐Kuka, M., Zvejniece, L., Švalbe, B., Vilšķe̅rsts, R., & Dambrova, M. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0224-9 · Cited by 26
“Clinical studies have shown that pre-diabetes is an intermediate condition associated with specific microvascular alterations, including neuropathy [20, 21] and cognitive impairment [22].”
BackgroundZhou, Y., You, Y., Zhang, Y., Zhang, Y., Yuan, C., & Xu, X. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100164 · Cited by 27
Wang, N., Zhao, Y., Wu, M., Li, N., Yan, C., Guo, H., Li, Q., Li, Q., & Wang, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03589-0 · Cited by 24
“Compared to individuals with mild cognitive impairment (MCI), diabetes and pre-diabetes significantly accelerate the progression from MCI to dementia [4].”
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 25
Dybjer, E., Engström, G., Helmer, C., Nägga, K., Rorsman, P., & Nilsson, P. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14267 · Cited by 24
Prevalence and incidence of mild cognitive impairment in adults with diabetes in the United States
Zheng, Y., Ma, Q., Qi, X., Zhu, Z., & Wu, B. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110976 · Cited by 25
Łabieniec-Watała, M., Karolczak, K., Siewiera, K., & Watała, C. W. (2013) · Molecules · doi:10.3390/molecules181113769 · Cited by 23
“histological and neuroimaging techniques [57–59], have clearly demonstrated that the risk of mental illness is significantly increased in poorly controlled diabetes [60] and that preexisting diabetes is associated with earlier development of the onset of dementia and decreased survival time following the”
BackgroundCerebral microbleeds, cognitive impairment, and MRI in patients with diabetes mellitus
Zhou, H., Yang, J., Xie, P., Dong, Y., You, Y., & Liu, J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.04.019 · Cited by 23
Teng, Z., Feng, J., Liu, R., Dong, Y., Chen, H., Xu, J., Jiang, X. J., Li, R., & Lv, P. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s368725 · Cited by 25
Novel targets and therapies of metformin in dementia: old drug, new insights
Cui, W., Lv, C., Geng, P., Fu, M., Zhou, W., Xiong, M., & Li, T. X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415740 · Cited by 22
Vascular neurocognitive disorders and the vascular risk factors
Albu, C. V., Pădureanu, V., Boldeanu, M. V., Bumbea, A. M., Enescu, A. Ş., Albulescu, D. M., Siloşi, C. A., & Enescu, A. (2018) · Journal of Mind and Medical Sciences · doi:10.22543/7674.51.p715 · Cited by 23
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
Edlund, A. K., Chen, K., Lee, W., Protas, H., Su, Y., Reiman, E., Caselli, R., & Nielsen, H. M. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210065 · Cited by 22
Gordon, C. A., & Martin, D. J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.856265 · Cited by 22
Risk Factors for Mild Cognitive Impairment in German Primary Care Practices
Jacob, L., Bohlken, J., & Kostev, K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160875 · Cited by 23
“Since the latter condition is a known risk factor for cognitive impairment and dementia [7, 25], it could be behind the positive association between anxiety/depression and MCI.”
Latest advances on interventions that may prevent, delay or ameliorate dementia
Wilson, D., Peters, R., Ritchie, K. A., & Ritchie, C. W. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310397636 · Cited by 22
“However, a recent study [Xu et al. 2010] concluded that borderline diabetes may interact with severe systolic hypertension to multiply the risk of AD.”
BackgroundResultAssociations between epigenetic aging and diabetes mellitus in a Swedish longitudinal study
Shemer, D. W., Mostafaei, S., Tang, B., Pedersen, N. L., Karlsson, I., Fall, T., & Hägg, S. (2024) · GeroScience · doi:10.1007/s11357-024-01252-7 · Cited by 20
“Age has been identified as a major risk factor for T2D [5] and individuals with advanced T2D exhibit organ system dysfunction like that observed in aging [6–8].”
BackgroundZeng, J., Hu, K., Wang, Z., Huang, Y.-C., Zhang, Y., Peng, H., & Ma, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00086 · Cited by 20
Expert Consensus on Cognitive Dysfunction in Diabetes
Yang, Y., Zhao, J., & Yu, X. (2022) · Current Medical Science · doi:10.1007/s11596-022-2549-9 · Cited by 18
Increased risk of dementia in Type 1 diabetes: A systematic review with meta-analysis
Li, L., Wong, D. K., Fisher, C. A., CONN, J. J., WRAIGHT, P. R., Davies, A., Barson, E., & Pike, K. E. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112043 · Cited by 20
Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes
Piątkowska‐Chmiel, I., Herbet, M., Gawrońska‐Grzywacz, M., & Dudka, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105502 · Cited by 21
Epidemiology of Alzheimer’s Disease
Xu, W., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54398 · Cited by 22
Self-citationIncreasing Burden of Complex Multimorbidity Across Gradients of Cognitive Impairment
Koroukian, S. M., Schiltz, N. K., Warner, D. F., Stange, K. C., & Smyth, K. A. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517726388 · Cited by 19
“Findings from recent studies highlight the bidirectional nature of the association between CI and MM, showing longitudinal changes in cognitive function and accelerated deterioration in physical health, defined as the faster accumulation of MM over time.(49,50) Second, our study does not account for the care received…”
BackgroundGirges, C., Vijiaratnam, N., Athauda, D. S., Auld, G., Gandhi, S., & Foltynie, T. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00853-7 · Cited by 18
Xu, W., Pedersen, N. L., Keller, L., Kalpouzos, G., Wang, H., Graff, C., Winblad, B. G., Bäckman, L., & Fratiglioni, L. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001853 · Cited by 18
Self-citationNam, S. M., Kim, J. W., Yoo, D. Y., Jung, H. Y., Choi, J. H., Hwang, I. K., Seong, J. K., & Yoon, Y. S. (2016) · Journal of Veterinary Science · doi:10.4142/jvs.2016.17.1.13 · Cited by 19
Dong, W., Zhou, Y., Li, P., Zhang, P., Li, J., Wang, Y., Li, X., Bian, Z., Yin, S., & Xu, Y. (2020) · Journal of Neural Engineering · doi:10.1088/1741-2552/ab8b7b · Cited by 17
Taking hypoglycaemia seriously: diabetes, dementia and heart disease
Holt, P. (2011) · British Journal of Community Nursing · doi:10.12968/bjcn.2011.16.5.246 · Cited by 17
Importance of Hypertension and Social Isolation in Causing Sleep Disruption in Dementia
Eshkoor, S. A., Hamid, T. A., Nudin, S. S. H., & Mun, C. Y. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513505136 · Cited by 17
The ER stress-autophagy axis: implications for cognitive dysfunction in diabetes mellitus
Zhu, Q. (2020) · Clinical Science · doi:10.1042/cs20200235 · Cited by 17
Tang, X., Wang, Y., Simó, R., Stehouwer, C. D. A., & Zhou, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220972 · Cited by 15
Nutritional assessment models for diabetes and aging
Wen, Y., Liu, Y., Huang, Q., Farag, M. A., Li, X., Wan, X., & Zhao, C. (2022) · Food Frontiers · doi:10.1002/fft2.168 · Cited by 15
Qiu, C. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.146 · Cited by 16
Self-citationDong, W., Li, P., Li, X., Wei, Z., Zhou, Y., Pei, H., Li, F., Bian, Z., Wang, L., & Yin, S. (2020) · Neural Networks · doi:10.1016/j.neunet.2020.01.025 · Cited by 15
New Insight into Metformin Mechanism of Action and Clinical Application
Yan, Y., Kover, K. L., & Moore, W. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91148 · Cited by 13
Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance
Al‐Lahham, R., & Méndez, N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230392 · Cited by 13
“ate conversion from mild cognitive impairment to dementia [77].”
Analysis of Risk Factors for Vascular Cognitive Impairment in Patients with Cerebral Infarction
An, X.-L., & Li, C. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0246-4 · Cited by 14
Bell, T. R., Dávila, A. L., Clay, O. J., Markides, K. S., Andel, R., & Crowe, M. G. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217000746 · Cited by 15
Active-site environment of Cu bound amyloid β and amylin peptides
Pal, I., Roy, M., & Dey, S. G. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01724-8 · Cited by 13
“Among these Alzheimer’s disease (AD) and Type 2 diabetes mellitus (T2Dm) are two of the most prevalent diseases in the elderly population worldwide [7, 8].”
BackgroundKim, E. W., Kim, K. Y., & Kim, E. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100444 · Cited by 13
“InMCIindividuals,thepathologicalprocessesandneurodegeneration associated with AD are more advanced [43,44,48], indicating compromised compensatory mechanism in response to metabolic stressors [42].”
O'Toole, S. M., Walker, R. J., Garacci, E., Dawson, A. Z., Campbell, J. A., & Egede, L. E. (2022) · BMC Geriatrics · doi:10.1186/s12877-021-02740-7 · Cited by 13
Li, Z., Wang, S., Liu, S., Gong, X., Wang, Y., Wu, D., Yang, M., Li, R., Li, H., Li, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.997260 · Cited by 12
Effects of orthostatic hypotension on cognition in type 2 diabetes mellitus
Zhang, J., Chi, H., Wang, T., Shen, T., Wang, H., Yuan, X., & Li, Z. (2019) · Annals of Neurology · doi:10.1002/ana.25578 · Cited by 12
“Type 2 diabetes has been linked with cognitive deficits, accelerated age-related cognitive decline, and increases the risk of cognitive impairment and dementia.(5,6) DM is a risk factor for OH due to arterial wall stiffness, which in turn reduces the vasoreactivity of the vascular bed to compensate for BP variation.”
BackgroundSelf-citationRotonen, S., AUVINEN, J. P., Bloigu, A. H., Härkönen, P. K., Jokelainen, J. J., Timonen, M., & Keinanen-Kiukaanniemi, S. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109045 · Cited by 11
Activation of Insulin Signaling in Adipocytes and Myotubes by Sarcopoterium Spinosum Extract
Ben‐Shachar, M., Rozenberg, K., Skalka, N., Wollman, A., Michlin, M., & Rosenzweig, T. (2019) · Nutrients · doi:10.3390/nu11061396 · Cited by 11
“In addition to its critical role in the development of the disease, insulin resistance has wide ranging consequences, and is considered as the underlying pathological mechanism of several other disorders such as poly cystic ovary syndrome, non-alcoholic fatty liver diseases, as well as dementia and Alzheimer disease […”
BackgroundBiomarkers of Renal Function in Type 2 Diabetic Patients with Cognitive Impairment
Zhang, J., Geng, N., Li, Z., Qiao, H.-J., Sun, H., & Li, F. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.059 · Cited by 12
Niikawa, T., Ozeki, T., Kato, M., & Ikoma, Y. (2008) · Horticultural Research (Japan) · doi:10.2503/hrj.7.123 · Cited by 11
Lima, J. E. B. D. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-01082019-101404 · Cited by 14
Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Sjöholm, Å., Bennet, L., & Nilsson, P. M. (2025) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2025.2455136 · Cited by 10
“Patients with t2D have a ~20% increased risk of this condition [7–10], and in addition an increased risk of transition to manifest dementia [21,22].”
Zhang, G., Liu, T., Wei, W., Zhang, R., Wang, H., & Wang, M. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1032264 · Cited by 10
“While mild cognitive impairment is an independent cause of dementia with conversion rates of 50%, the co-occurrence of diabetes will further increase the risk (Velayudhan et al., 2010; Xu et al., 2010).”
BackgroundSelf-citationYu, C., Wang, Y., Zhang, B., Xiang, X., Zhang, W., Ding, Q., Miao, Y., Hou, Y., Ma, X., Wu, T., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15376 · Cited by 10
“3,4 To date, no effective therapies can arrest or revert the dementia process, but up to 40% of dementia cases may be prevented or delayed if modifiable risk factors are controlled early.”
BackgroundMathisen, A. F., Legøy, T. A., Larsen, U., Unger, L., Abadpour, S., Paulo, J. A., Scholz, H., Ghila, L., & Chera, S. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111951 · Cited by 10
“This, combined with the accelerated onset of age-related diseases in diabetes patients, indicates that diabetes can be both a consequence and driver of ageing (Palmer et al., 2019; Xu, 2010; Aronson and Edelman, 2014).”
BackgroundLi, J., Guo, Y., Li, Q., Miao, K., Wang, C., Zhang, D., Tian, C., & Suhe, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.918557 · Cited by 11
Shimoda, M., Kaneko, K., Nakagawa, T., Kawano, N., Otsuka, R., Ota, A., Naito, H., Matsunaga, M., Ichino, N., Yamada, H., et al. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20210128 · Cited by 10
Lai, S., Kang, Z., Sun, J., Wang, Z., Xu, Y., Xing, S., Feng, M., Wang, Y., & Liu, H. (2025) · Brain Sciences · doi:10.3390/brainsci15050480 · Cited by 9
Rosness, T. A., Engedal, K., Bjertness, E., & Strand, B. H. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13870 · Cited by 8
Hagar, A. A., Ashour, Y., El-Razek, R. A., Elsamahy, M., & Shehab, O. (2018) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-018-0018-y · Cited by 8
“Finally, type 2 DM was suggested by Roberts et al. (2014) to be the factor of increasing the risk of cognitive impairment acceleration and development of MCI into dementia, furthermore resulting in hippocampal atrophy which may end in QEEG changes (Ganguli et al. 2004; Hussain 2007; Xu et al. 2010).”
BackgroundFeng, J., Teng, Z., & Chen, S. (2025) · PeerJ · doi:10.7717/peerj.19442 · Cited by 7
“( You et al., 2021 ) and accelerated cognitive decline from MCI to dementia ( Srikanth et al., 2020 ; Biessels & Whitmer, 2020 ; Xu et al., 2010 ).”
Peripherally administered amylin inhibits stress-like behaviors and enhances cognitive performance
Laugero, K. D., Tryon, M. S., Mack, C. M., Caldarone, B. J., Hanania, T., McGonigle, P., Roland, B. L., & Parkes, D. G. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113668 · Cited by 7
Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's disease
Schwartz, S. S., Rhea, E. M., Banks, W. A., & Herman, M. E. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70008 · Cited by 7
“Two longitudinal studies include the Kungsholmen Project Xu 2010 25 and the 12 ‐ year follow ‐ up Finnish study.”
Prevention of Alzheimer’s Disease: Intervention Studies
Mangialasche, F., Xu, W., & Kivipelto, M. (2013) · InTech eBooks · doi:10.5772/55034 · Cited by 9
“Similar situations exist for heart failure, which increases the risk of dementia among older adults [68], and diabetes mellitus, which accelerates the progression from mild cognitive impairment to dementia by more than 3 years [164].”
BackgroundSelf-citationCerebrovascular and Neurodegenerative Pathologies in Long-Term Stable Mild Cognitive Impairment
Sharma, M. J., & Callahan, B. L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200829 · Cited by 9
Gould, C. E., Beaudreau, S. A., & Salman, H. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212001196 · Cited by 7
Population attributable fractions of a wide range of peripheral diseases for the burden of dementia
Deng, Z., Yang, Y., Lin, Q., Xiao, S., Zuo, Y., Wang, J., Xu, Y., Li, H., Xie, D., Dai, Q., et al. (2026) · Nature Human Behaviour · doi:10.1038/s41562-025-02392-2 · Cited by 6
Oulhaj, A., & Martín, E. S. (2012) · Journal of Statistical Computation and Simulation · doi:10.1080/00949655.2012.700714 · Cited by 6
Marra, A., Naro, A., Chillura, A., Bramanti, A., Maresca, G., Luca, R. D., Manuli, A., Bramanti, P., & Calabrò, R. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170973 · Cited by 6
Song, K., Zhang, R., Zhao, X., Yang, L., Wang, Q., & Gao, W. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02583-9 · Cited by 6
“With aging, the cognitive function of patients with T2DM is decreased by twofold compared to non-diabetic patients [12], while the risk of dementia is increased by 1.5–threefold [13, 14].”
InfluentialBrain glucose hypometabolism and hippocampal inflammation in Goto-Kakizaki rats
Borges, J. C. D. O., de Oliveira, V. A. B., Serdan, T. D. A., Silva, F. L. R., Santos, C. S., Pauferro, J. R. B., Ribas, A. D. S. F., Manoel, R., Pereira, A. C. G., Correa, I. S., et al. (2023) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2023e12742 · Cited by 6
“Additionally, insulin and leptin resistance can potentially exacerbate the dysregulation in brain glucose and lipid metabolism, contributing to increased neuroinflammation and neurodegeneration processes (35,40).”
BackgroundDiabetes Mellitus and Cognitive Decline – Prevention Should Not Be Delayed!
Sinclair, A. J., & Vellas, B. J. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.9 · Cited by 7
“It has been observed that diabetes in the presence of hypertension leads to a more pronounced cognitive decline (4) and that at an early stage of cognitive decline (mild cognitive impairment (MCI)), diabetes accelerates the progression of MCI to dementia (5).”
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Liang, M., et al. (2024) · eLife · doi:10.7554/elife.99462.3 · Cited by 6
Zhang, J., Jiang, J., Li, H., Deng, J., Dong, W., & Deng, H. (2025) · Brain Sciences · doi:10.3390/brainsci15111157 · Cited by 6
“According to studies, diabetes increases the risk of cognitive dysfunction and dementia by 1.25 to 1.91 times [7], and approximately one out of every ten cases of dementia worldwide is associated with diabetes [8].”
InfluentialBi, S., Guo, D., Tan, H., Chen, Y., & Li, G. (2025) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s519049 · Cited by 5
Oxidative Stress, DNA Damage and Repair Pathways in Patients with Type 2 Diabetes Mellitus
Lima, J. E. B. D. F., Xavier, D. J., & Sakamoto‐Hojo, E. T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85438 · Cited by 7
Akgun, F. B., TUĞLU, N. S., AÇIL, Y. G., & Eruygur, N. (2023) · Eurasian Journal of Biological and Chemical Sciences · doi:10.46239/ejbcs.1228402 · Cited by 5
Diabetes and cognitive dysfunction
Sinclair, A. J. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch29 · Cited by 5
Appraisal of cognitive function of diabetics in a rural healthcare teaching institute
Sarker, G., Bandyopadhyay, A., Mohanta, P., Kumar, K., Sarbapalli, D., & Pal, R. (2016) · Annals of Tropical Medicine and Public Health · doi:10.4103/1755-6783.168686 · Cited by 5
Eom, S., & Ha, J.-Y. (2021) · Journal of Korean Gerontological Nursing · doi:10.17079/jkgn.2021.23.3.297 · Cited by 5
Injurious Falls before, during, and after Stroke Diagnosis: A Population-based Study
Zhang, L., Wang, J., Dong, X., Dove, A. E., Sakakibara, S., Liu, X., Wang, C., Wang, Z., Welmer, A., & Xu, W. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.105465 · Cited by 5
Self-citationMiura, Y., Tsumoto, H., Masui, Y., Inagaki, H., Ogawa, M., Ideno, Y., Kawakami, K., Umezawa, K., Kabayama, M., Akagi, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130316 · Cited by 4
Das, M., Chakraborty, M., Das, P., Santra, S., Mukherjee, A., Das, S., Bànyai, K., Roy, S., Choudhury, L., Gupta, R., et al. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103176 · Cited by 5
Zakharova, I. O., Bayunova, L. V., Derkach, K. V., Ilyasov, I. O., Shpakov, A. O., & Avrova, N. F. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022020077 · Cited by 4
Trivedi, R., Sıngh, S., Singh, V. K., Yadav, S., Singh, A. C., Singh, A., Chaurasia, R. N., Kumar, A., & Kumar, D. (2024) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2024.10.001 · Cited by 4
Predicting Mild Cognitive Impairment in Type 2 Diabetes: A Machine Learning Approach
Li, F., Zhao, S., Wu, T., Yang, S., Duan, Y., Sun, J., Zhu, W., Zhai, B., Yu, C., Chen, S., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/7304414 · Cited by 3
“A longitudinal study further showed that MCI in diabetic patients accelerates the onset of dementia by an average of 3.18 years [5].”
InfluentialJoyce, O., McHugh, C., Mockler, D., Wilson, F., & Kelly, Á. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327408 · Cited by 3
“Exposure to T2DM during midlife has been shown to accelerate neurodegeneration and structural neuropathology [3], while high levels of blood glucose with advancing age can impact the circulatory, renal and peripheral nervous systems [4].”
Xing, X., Wang, Y., Shen, Z., Pan, F., & Cai, G. (2023) · Diabetic Medicine · doi:10.1111/dme.15180 · Cited by 3
Durazo, A. A., Weigand, A. J., Bangen, K. J., Membreno, R., Mudaliar, S. R. D., & Thomas, K. R. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230917 · Cited by 3
Loneliness, Cognitive Functioning, and Quality of Life in Older Adults.
Naveed, M., Riaz, A., & Malik, N. (2022) · Forman Journal of Social Sciences · doi:10.32368/fjss.20220110 · Cited by 3
Papadimitriou, A., Dawson, A. Z., Thorgerson, A. A., Bhandari, S., Martínez, M., & Egede, L. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231107 · Cited by 4
“Scores indicate a range from normal to mild cognitive impairment (MCI) to severe dementia [10].”
Teng, Z., Feng, J., Xie, X., Xu, J., Jiang, X. J., & Lv, P. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s451862 · Cited by 3
“8,12,13 In addition, VCI, especially VaD, may lead to poor self-management of T2DM, which in turn leads to more cerebrovascular events and poorer cognitive function.”
Piątkowska‐Chmiel, I., Gawrońska‐Grzywacz, M., Pawłowski, K., Dudka, J., Ślaska, B., Tkaczyk‐Wlizło, A., Kowal, K., & Herbet, M. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240517094428 · Cited by 3
“It is estimated that 20-70% of people with diabetes experience cognitive deficits [9-11].”
Li, P., Abuloha, S., Alshehri, A., Alkhuzam, K. A., Jaffee, M. S., Ospina, N. S., & Shao, H. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2024.100008 · Cited by 5
Metadata
- Authors
- Xu, W., Caracciolo, B., Wang, H.-X., Winblad, B., Bäckman, L., Qiu, C., & Fratiglioni, L.
- Affiliations
- Stockholm University (SE)
- Corresponding author
- Xu, Weili
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-16
- Volume
- 59
- Issue
- 11
- Pages
- 2928-2935
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963552
- OpenAlex
- W2138030160
- Cited by
- 260
- References
- 47
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 21 · 2023: 18 · 2022: 14 · 2021: 22 · 2020: 19 · 2019: 18 · 2018: 14 · 2017: 13 · 2016: 9 · 2015: 15 · 2014: 26 · 2013: 20 · 2012: 13
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Karolinska Institutet
- Vetenskapsrådet
- Swedish Brain Power
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- prediabetes, mild cognitive impairment, dementia, conversion to dementia, amnestic mild cognitive impairment, older adults, incident dementia
- MeSH terms
- Aged, Aged, 80 and over, Amnesia, Cognition Disorders, Cross-Sectional Studies, Dementia, Diabetes Mellitus, Educational Status, Female, Follow-Up Studies, Humans, Male, Prediabetic State, Severity of Illness Index, Incidence, Disease Progression, Risk Assessment, Stroke, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

